36E79726R0035_1.docx
DOCX document 26 KB Posted
- Attached to
- 6505--2027-2028 Influenza Virus Vaccine
- Solicitation number
- 36E79726R0035
About this file
This is a Presolicitation Notice for a federal procurement of influenza virus vaccines for the 2027-2028 influenza season. The Department of Veterans Affairs National Acquisition Center intends to issue an unrestricted Request for Proposal (RFP 36E79726R0035) to supply influenza vaccines to the VA, State Veteran Homes option 2 (SVH2), Bureau of Prisons (BOP), Indian Health Service (IHS), and Captain James A. Lovell Federal Health Care Center (FHCC). The solicitation will be issued in commercial item format in accordance with FAR Part 12 on or about September 8, 2026, with a closing date of September 24, 2026, and a response deadline of 2:30 PM Central Time on September 8, 2026.
The procurement requires three line items of pre-filled single-dose syringes with plunger and Luer lock needle attachment, with total estimated annual requirements of 153,879 units (general population), 121,680 units (65 years and older), and 1,000 units (pediatric 6-35 months). Vaccines must be Trivalent or Quadrivalent formulations that are latex and preservative-free, with final presentations based on World Health Organization recommendations. Offerors must offer the full quantity for each line item selected and must price all offered line items at the same unit price, including the Cost Recovery Fee and Federal Excise Tax. Delivery is required Free On Board (FOB) Destination to facilities throughout the United States, Philippines, and Puerto Rico, with the first shipment (minimum 50% of each facility's order) due between August 15-September 15, 2027, and the second shipment due between September 16-October 15, 2027. FHCC requires 100% delivery by September 15, 2027. Evaluation and award will be made by solicitation line item for each agency. The contracting office is located at the Department of Veterans Affairs, Building 37, Chicago, Illinois 60141, with the point of contact being Contract Specialist Deborah Fassl at Deborah.Fassl@va.gov or 708-786-5894.
View the file
On GovTribe
Work with this file
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
Presolicitation Notice Presolicitation Notice
| SUBJECT* |
| 2027-2028 Influenza Virus Vaccine |
GENERAL INFORMATION
| CONTRACTING OFFICE’S ZIP CODE* |
| 60141 |
| SOLICITATION NUMBER* |
| 36E79726R0035 |
| RESPONSE DATE/TIME/ZONE |
| 09-08-2026 2:30 PM CENTRAL TIME, CHICAGO, USA |
| ARCHIVE |
| 99 DAYS AFTER THE RESPONSE DATE |
SET-ASIDE
| PRODUCT SERVICE CODE* |
| 6505 |
| NAICS CODE* |
| 325412 |
PLACE OF PERFORMANCE
POSTAL CODE
COUNTRY
CONTACT INFORMATION
| CONTRACTING OFFICE ADDRESS |
| Department of Veterans Affairs |
OPAL / National Acquisition Center Building 37 1st Avenue, One Block North of Cermak
POINT OF CONTACT*
Contract Specialist Deb Fassl Deborah.Fassl@va.gov 708-786-5894
ADDITIONAL INFORMATION
AGENCY’S URL
URL DESCRIPTION
| AGENCY CONTACT’S EMAIL ADDRESS |
| Deborah.Fassl@va.gov |
| EMAIL DESCRIPTION |
| Agency POC Email |
DESCRIPTION
PRE-SOLICITATION NOTICE: The VA National Acquisition Center intends to issue a Request for Proposal (RFP) 36E79726R0035 for an unrestrictive procurement for the Influenza Virus Vaccine for the Department of Veterans Affairs (VA) – to include State Veteran Homes option 2 (SVH2’s), Bureau of Prisons (BOP), Indian Health Service (IHS), and Captain James A. Lovell Federal Health Care Center (FHCC) for the 2027-2028 Influenza Season.
Evaluation and award will be made by solicitation line item for VA, BOP, IHS, and FHCC requirements. Offerors are not required to submit an offer for every line item; however, the offeror must offer the full quantity for each line item offered. Additionally, all offered line items for a single presentation must be offered at the same unit price. Please note that the final offered price must include the Cost Recovery Fee (CRF) and Federal Excise Tax (FET).
Orders will be placed by and delivered to VA, SVH2, BOP, and IHS facilities throughout the United States, the Philippines and Puerto Rico. The contractor(s) will be required to deliver the vaccine Free On Board (FOB) Destination to Government facilities within the U.S., Philippines, and Puerto Rico. The first shipment of product ordered must be at least 50% of each individual facility’s ordered quantity and must be delivered between August 15, 2027, and September 15, 2027. The second shipment must be for the remaining individual facility’s entire ordered quantity and must be delivered between September 16, 2027, and October 15, 2027.
FHCC shall receive 100% of the awarded quantities between August 15, 2027 and September 15, 2027.
Solicitation number 36E79726R0035 is estimated to be electronically issued in commercial item format in accordance with FAR Part 12 on or about September 8, 2026, with a closing date of September 24, 2026.
ESTIMATED ANNUAL REQUIREMENTS BY AGENCY
| PRESENTATION |
| DESCRIPTION |
| PACKAGE TYPE |
| VA EST ANNUAL USAGE |
| BOP EST ANNUAL USAGE |
| IHS EST ANNUAL USAGE |
| FHCC EST ANNUAL USAGE |
| TOTAL ESTIMATED ANNUAL USAGE |
| 1 |
| Influenza Virus Vaccine: Pre-filled single dose syringes with plunger and Luer lock needle attachment, Trivalent or Quadrivalent; 2027-2028 influenza season; latex and preservative free: for persons ≥ 36 months. |
| SYRINGE (Box of 10) |
| 120,000 |
| 6,129 |
| 27,200 |
| 550 |
| 153,879 |
| 2 |
| I Influenza Virus Vaccine: Pre-filled single dose syringe with plunger and Luer lock needle attachment, Trivalent or Quadrivalent; 2027-2028 influenza season; latex and preservative free; must be specifically designed for persons 65 years and older as approved by the FDA. |
| SYRINGE (Box of 10) |
| 110,000 |
| 280 |
| 11,000 |
| 400 |
| 121,680 |
| 3 |
| Influenza Virus Vaccine: Pre-filled single dose syringe with plunger and Luer lock needle attachment, Trivalent or Quadrivalent; 2027-2028 influenza season. Must be split virus vaccine (subvirion or purified surface antigen) that has been FDA approved and labeled with indications for administration to children 6 months - 35 months of age (pediatric), latex and preservative free. |
| SYRINGE (Box of 10) |
| 0 |
| 0 |
| 1,000 |
| 0 |
| 1,000 |
The final vaccine presentation for each line item (Trivalent or Quadrivalent) shall be based on recommendations issued by the World Health Organization (WHO). If WHO recommends both Trivalent and Quadrivalent influenza strain presentations, and both are commercially available from the offeror or contract awardee, the Trivalent presentation shall be required.
| *=Required Field |
| Presolicitation Notice |
Presolicitation Notice
File details come from the government source that posted it. Updated .